8-K/A filing — ChronoScale Holdings Corp (CHRN)
Filed: 2026-11-18 AccNo: 0001493152-26-053013 Size: 12 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Filed: 2026-11-18 AccNo: 0001493152-26-052998 Size: 2 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 5.07: Submission of Matters to a Vote of Security Holders Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-11-18 AccNo: 0001493152-26-053013 Size: 12 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
ChronoScale AI contracts support a $1 billion annualized revenue run rate by Q3 2027 as the company completes its Ekso sale.
ChronoScale announced new and expanded customer agreements for AI infrastructure deployments that are expected to drive annualized revenue run-rate to $1 billion by Q3 2027. The company also completed the sale of its Ekso Bionics business unit to focus resources on its core accelerated compute and AI infrastructure operations.